Macrocycles to target influenza viral hemagglutinin as bifunctional potent broad-spectrum antiviral agent
Project/Area Number |
15K15146
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Virology
|
Research Institution | Tokyo Metropolitan Institute of Medical Science |
Principal Investigator |
KOHARA Michinori 公益財団法人東京都医学総合研究所, ゲノム医科学研究分野, 特任研究員 (10250218)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 特殊環状ペプチド / 治療 / インフルエンザ / 高病原性鳥インフルエンザ / 病態抑制機序 / 高病原性トリインフルエンザウイルス / ウイルス / 感染症 / 微生物 / 免疫学 |
Outline of Final Research Achievements |
HA-targeted antibodies have the potential to neutralize HA-mediated virion-cell binding. To devise smaller molecules capable of binding to the influenza viral HA and have the potential as an antiviral agent, we used an emerging technology, RaPID system. After five rounds of selection, we found an appreciable increase in the cDNA recovery rate and sequencing of 69 molecular clones from the selected cDNAs revealed a total of 28 candidates for inhibitor HA (iHA). In order to investigate the influence of iHA-100 on the pathology of H5N1 infection, a comprehensive analysis of cytokines was performed. Inflammatory cytokines (IFN-ganma, IL-6) in the lung of iHA-100-treated monkeys were significantly reduced. These results suggest that H5N1-induced inflammation and pathogenesis was suppressed by administration of iHA-100. iHA-100 is a promising antiviral agent that exhibited the inhibitory effect of both virus replication and pathogenesis in vivo.
|
Report
(4 results)
Research Products
(24 results)
-
[Journal Article] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model2017
Author(s)
Yuko Tokunaga, Yosuke Osawa, Takahiro Ohtsuki, Yukiko Hayashi, Kenzaburo Yamaji, Daisuke Yamane, Mitsuko Hara, Keisuke Munekata, Kyoko Tsukiyama-Kohara, Tsunekazu Hishima, Soichi Kojima, Kiminori Kimura, and *Michinori Kohara
-
Journal Title
Scientific Reports
Volume: 7
Issue: 1
Pages: 325-325
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.2017
Author(s)
2.Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, Okusaka T, Morita S, Inoue K, Kanto T, Todaka K, Nakanishi Y, Kohara M, Mizokami M.
-
Journal Title
EBioMedicine
Volume: 23
Pages: 79-87
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Immature Core protein of hepatitis C virus induces an unfolded protein response through inhibition of ERAD-L in a yeast model system2016
Author(s)
Takahashi S, Sato N, Kikuchi J, Kakinuma H, Okawa J, Masuyama Y, Iwasa S, Irokawa H, Hwang GW, Naganuma A, Kohara M, *Kuge S.
-
Journal Title
Genes Cells
Volume: 22
Issue: 2
Pages: 160-173
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Sensitization with vaccinia virus harboring hemagglutinin recovers the immune potential against highly pathogenic H5N1 influenza virus in non-human primates2016
Author(s)
Fumihiko Yasui, Yasushi Itoh, Ai Ikejiri, Masahiro Kitabatake, Nobuo Sakaguchi, Keisuke Munekata, Shintaro Shichinohe, Yukiko Hayashi, Hirohito Ishigaki, Misako Nakayama, Yoshihiro Sakoda, Hiroshi Kida, Kazumasa Ogasawara, *Michinori Kohara
-
Journal Title
Scientific Reports
Volume: 6
Issue: 1
Pages: 37915-37915
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody.2016
Author(s)
Sugata K, Yasunaga JI, Miura M, Akari H, Utsunomiya A, Nosaka K, Watanabe Y, Suzushima H, Koh KR, Nakagawa M, Kohara M, Matsuoka M.
-
Journal Title
Scientific report
Volume: 6
Issue: 1
Pages: 27150-27150
DOI
NAID
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus antigen in non-human primate model2015
Author(s)
Tomoko Fujiyuki, Ryo Horie, Misako Yoneda, Takeshi Kuraishi, Fumihiko Yasui, Hyun-jeong Kwon, Fusako Ikeda, Keisuke Munekata, Miho Ishii, Yuri Kiso, Mio Omi, Hiroki Sato, Hiroshi Kida, Shosaku Hattori, Michinori Kohara, Chieko Kai
Organizer
第63回日本ウイルス学会学術集会
Place of Presentation
福岡国際会議場(福岡県・福岡市)
Year and Date
2015-11-22
Related Report
-
-
-
-
-